Navigation Links
Theratechnologies: TH9507 Phase 3 Clinical Update

trolled study conducted in 66 centers in North America and Europe. It is designed to confirm the results of the earlier Phase 3 trial by examining the safety and efficacy of a daily administration of 2 mg of TH9507 for a period of 26 weeks. The primary endpoint is a reduction of visceral adipose tissue, or VAT. In August 2006, the protocol for this second Phase 3 trial was approved by the Food and Drug Administration (FDA) in the United States through the Special Protocol Assessment (SPA) process.

"We have now secured the necessary regulatory approvals for the European arm of our trial," said Yves Rosconi, President and Chief Executive Officer of Theratechnologies. "All of the data we have presented thus far indicate that TH9507 may offer an attractive combination of efficacy and safety with potential advantages over other approaches being developed. This is potentially very good news for patients and this marks the first time that our drug is being made available to European HIV-associated lipodystrophy patients," Mr. Rosconi stated.

HIV-associated Lipodystrophy

HIV-associated lipodystrophy is characterized by a change in the distribution of adipose tissue (fat containing tissue), dyslipidemia and glucose intolerance. The changes in fat distribution include visceral fat accumulation and/or loss of subcutaneous fat, generally in the limbs and in the face. There is no treatment available for the accumulation of visceral fat found in patients with HIV-associated lipodystrophy. It is estimated that approximately 250,000 HIV-infected patients in North America and Europe suffer an excessive accumulation of visceral fat.

About ENDO

ENDO is the annual meeting of the Endocrine Society, and is the largest meeting of its type in the world. Approximately 7,000 researchers, scientists, and clinicians from across the globe have assembled in Toronto for this premier meeting of hormone research and endocrinology.
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Theratechnologies Phase Clinical Update
(Date:5/22/2015)... N.C. , May 22, 2015  Research ... hosting its sixth Medical Affairs Roundtable ... (EDT) via a virtual roundtable to discuss "Medical ... Best Practices, Medical Affairs Consortium provides ... insights about the key challenges they face. The ...
(Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
(Date:5/22/2015)... , May 22, 2015  Amgen ... Company has commenced termination of its participation ... with AstraZeneca (LON:AZN, STO:AZN and NYSE: ... is in development for patients with moderate-to-severe ... The decision was based on events of ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... The U.S. Food and Drug Administration today issued new ... needle-free clinical devices to administer influenza vaccinations. Based on ... ) immediately discontinued use of such clinical devices at ... The Kroger family of pharmacies and The Little ...
... HAYWARD, Calif., Oct. 21, 2011 Intarcia ... a letter of intent with Quintiles , the world,s ... 3 program for Intarcia,s ITCA 650 (DUROS® subcutaneous continuous delivery ... GLP-1 therapy to better address the unmet needs of the ...
Cached Medicine Technology:Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 2Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 3Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 4
(Date:5/23/2015)... 23, 2015 With the implementation of ... finding it increasingly difficult to provide their employees with ... provide adequate insurance for employees stand to face strict ... an integral part of a business’s success or failure. ... businesses, Online USA Doctors has created a varying level ...
(Date:5/23/2015)... NY (PRWEB) May 23, 2015 On ... that, “the company has been the target of ... a part of the company’s ongoing Information Technology (IT) ... health insurers.” , The most notable attack on ... when Anthem Inc., the nation’s second largest health insurer, ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
(Date:5/23/2015)... Manufacturers are now required to produce water ... 8.2. Experts in the field agree that the regulation is ... HSPF score is what miles per gallon is to your ... Although the minimum HSPF score has been raised to 8.2, ... score north of 12. Indeed, the regulation was welcomed by ...
(Date:5/23/2015)... 2015 A live auction will be held ... surgery centers and other medical facilities around the United States. ... lab, radiology, surgery, anesthesia, exam and much more. , ... Thursday, May 28 starting at 9:00am CDT each day. The ... 25th Avenue, Melrose Park, IL 60160. Anyone can participate ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... September 20, 2011 Most parents recognize that the influence ... But, just how far do these influences reach? A study ... reports that adolescents are more likely to start drinking alcoholic ... The findings suggest that, in addition to well-established demographic ...
... Africa, women who are empowered to make household decisions tend ... study conducted by researchers at the Johns Hopkins Bloomberg School ... autonomy and the time since most recent sexual intercourse and ... activity. The full article will be published in the October ...
... selected a pediatric cancer survivor, Bella Rodriguez-Torres, as its 2011 ... award and $1,000 during the Awards Ceremony on Tuesday, October ... Miami Beach, Fla. , The Survivor Circle Award recognizes a ... devoted his or her time to helping others who are ...
... is all it could take to tell if you are ... of international scientists have discovered more than 10 types of ... a person who recently suffered a stroke or heart attack. ... collaboration led by Nanyang Technological University (NTU),s lead scientist, Assistant ...
... risk assessment calculator hosted at the World Health Organization ... ( http://www.shef.ac.uk/FRAX ), has now been released in version ... a desktop option, FRAX is becoming increasingly accessible to ... ,FRAX is now available for use without internet. ...
... is as effective as widely used antipsychotic drugs in managing ... side effects, a new study shows. The first major ... behavioural disturbances and social engagement in dementia patients found both ... researcher, Dr Lee-Fay Low, a Research Fellow in the School ...
Cached Medicine News:Health News:Extent of peer social networks influences onset of adolescent alcohol consumption 2Health News:Extent of peer social networks influences onset of adolescent alcohol consumption 3Health News:Increased responsibility could lead to decreased sexual activity among women 2Health News:Courageous 8-year-old honored with 2011 Survivor Circle Award 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 3Health News:FRAX calculator issued in version 3.4 2Health News:Humor as effective as medication in treating agitation in dementia 2
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The XE-2100 automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information....
... The CKX microscopes utilize the infinity-corrected optical ... cell checking. Olympus has taken this one ... modular design approach with the capability of ... images with digital imaging and video monitoring. ...
... The CX31 continue the ... the CH2 microscopes in ... now with UIS infinity-corrected ... improve all-around performance and ...
Medicine Products: